Sandro Wealth Management LLC Purchases New Stake in Danaher Corporation $DHR

Sandro Wealth Management LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 4,626 shares of the conglomerate’s stock, valued at approximately $3,331,000. Danaher comprises about 2.4% of Sandro Wealth Management LLC’s investment portfolio, making the stock its 12th biggest position.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter worth about $25,000. Main Street Group LTD acquired a new position in Danaher in the 1st quarter valued at about $25,000. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter valued at about $26,000. Elevated Capital Advisors LLC bought a new position in Danaher in the 4th quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher in the 4th quarter valued at about $27,000. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. UBS Group reduced their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Morgan Stanley reduced their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Finally, Royal Bank Of Canada upped their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Stock Performance

Shares of NYSE:DHR opened at $202.51 on Friday. The company’s 50 day moving average price is $193.14 and its two-hundred day moving average price is $193.21. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market cap of $142.37 billion, a PE ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Equities research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.